GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis Medha Baranwal5 July 2023 9:45 AM ISTTaiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like...
Faecal matter transplant beneficial in cirrhosis patients Medha Baranwal27 Jun 2023 11:15 AM ISTUK: A recent study has shown that faecal microbiota transplants (FMT) could treat patients with advanced cirrhosis by restoring their gut barrier...
Statins may reduce risk of severe liver disease among patients with chronic liver diseases Dr. Mahalakshmi Sivashankaran12 May 2023 11:15 AM ISTSweden: A study published in Clinical Gastroenterology and Hepatology has found that the use of statins, a commonly prescribed cholesterol-lowering...
Add on Noradrenaline to terlipressin infusion results in non-significantly higher rate of HRS resolution Dr. Shravani Dali8 May 2023 8:00 PM ISTThe combination of noradrenaline and terlipressin infusion results in a non-significantly higher rate of HRS resolution with significantly fewer...
Intermittent fasting improves health in patients with fatty liver disease Dr. Kamal Kant Kohli17 Feb 2023 9:15 AM ISTUSA: Adults with nonalcoholic fatty liver disease (NAFLD) who followed intermittent fasting with exercise were able to reduce hepatic steatosis,...
Treating NAFLD- 150 minutes of aerobic exercise per week reduces liver fat Dr. Kamal Kant Kohli9 Feb 2023 8:00 PM ISTThe U.S. Department of Health and Human Services has recommended 150 minutes of moderate to intense aerobic activity per week.Researchers at Penn...
Fast food consumption may raise risk of nonalcoholic fatty liver disease Dr. Kamal Kant Kohli12 Jan 2023 12:00 PM ISTCalifornia: Consumption of fast food is associated with NAFLD (nonalcoholic fatty liver disease), a potentially life-threatening condition...
Management of acute kidney injury in cirrhosis patients: Expert review on AGA's evaluation Medha Baranwal5 Jan 2023 11:30 PM ISTUSA: A recent article reports an expert review of the AGA (American Gastroenterological Association) clinical practice update on evaluating and...
Rifaximin and lactulose combo effectively, decreases mortality in hepatic encephalopathy Aditi15 Dec 2022 10:00 AM ISTChina: Metabolic disorders induce hepatic encephalopathy (HE), which causes severe liver disease and mismanaged central nervous system. Improving HE...
First-degree relatives of patients with NAFLD at risk of developing liver disease Dr. Kamal Kant Kohli3 Nov 2022 8:30 PM ISTNonalcoholic fatty liver disease (NAFLD) afflicts approximately one-fourth of the general population worldwide and it has emerged as an important...
Presence of parietal edema increases risk of ascitic fluid leak after paracentesis in liver cirrhosis patients Medha Baranwal25 Oct 2022 8:00 PM ISTMumbai: A minority of patients with cirrhosis develop persistent leaks after paracentesis, research published in the Journal of Clinical and...
Long-term carvedilol therapy reduces decompensation risk among cirrhosis patients Dr. Shravani Dali19 Oct 2022 7:30 PM ISTCarvedilol significantly decreases the risk of decompensation in patients with cirrhosis and clinically significant portal hypertension (CSPH),...
